Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel.

Identifieur interne : 000060 ( Ncbi/Checkpoint ); précédent : 000059; suivant : 000061

5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel.

Auteurs : Christopher P. Locher [États-Unis] ; Peter C. Ruben ; Jiri Gut ; Philip J. Rosenthal

Source :

RBID : pubmed:14638487

Descripteurs français

English descriptors

Abstract

To identify new leads for the treatment of Plasmodium falciparum malaria, we screened a panel of serotonin (5-hydroxytryptamine [5HT]) receptor agonists and antagonists and determined their effects on parasite growth. The 5HT1A receptor agonists 8-hydroxy-N-(di-n-propyl)-aminotetralin (8-OH-DPAT), 2,5-dimethoxy-4-iodoamphetamine, and 2,5-dimethoxy-4-bromophenylethylamine inhibited the growth of P. falciparum in vitro (50% inhibitory concentrations, 0.4, 0.7, and 1.5 microM, respectively). In further characterizing the antiparasitic effects of 8-OH-DPAT, we found that this serotonin receptor agonist did not affect the growth of Leishmania infantum, Trypanosoma cruzi, Trypanosoma brucei brucei, or Trichostrongylus colubriformis in vitro and did not demonstrate cytotoxicity against the human lung fibroblast cell line MRC-5. 8-OH-DPAT had similar levels of growth inhibition against several different P. falciparum isolates having distinct chemotherapeutic resistance phenotypes, and its antimalarial effect was additive when it was used in combination with chloroquine against a chloroquine-resistant isolate. In a patch clamp assay, 8-OH-DPAT blocked a P. falciparum surface membrane channel, suggesting that serotonin receptor agonists are a novel class of antimalarials that target a nutrient transport pathway. Since there may be neurological involvement with the use of 8-OH-DPAT and other serotonin receptor agonists in the treatment of falciparum malaria, new lead compounds derived from 8-OH-DPAT will need to be modified to prevent potential neurological side effects. Nevertheless, these results suggest that 8-OH-DPAT is a new lead compound with which to derive novel antimalarial agents and is a useful tool with which to characterize P. falciparum membrane channels.

DOI: 10.1128/aac.47.12.3806-3809.2003
PubMed: 14638487


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:14638487

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel.</title>
<author>
<name sortKey="Locher, Christopher P" sort="Locher, Christopher P" uniqKey="Locher C" first="Christopher P" last="Locher">Christopher P. Locher</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Tropical Medicine and Medical Microbiology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii 96816, USA. Christopher.locher@maxygen.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Tropical Medicine and Medical Microbiology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii 96816</wicri:regionArea>
<wicri:noRegion>Hawaii 96816</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ruben, Peter C" sort="Ruben, Peter C" uniqKey="Ruben P" first="Peter C" last="Ruben">Peter C. Ruben</name>
</author>
<author>
<name sortKey="Gut, Jiri" sort="Gut, Jiri" uniqKey="Gut J" first="Jiri" last="Gut">Jiri Gut</name>
</author>
<author>
<name sortKey="Rosenthal, Philip J" sort="Rosenthal, Philip J" uniqKey="Rosenthal P" first="Philip J" last="Rosenthal">Philip J. Rosenthal</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14638487</idno>
<idno type="pmid">14638487</idno>
<idno type="doi">10.1128/aac.47.12.3806-3809.2003</idno>
<idno type="wicri:Area/PubMed/Corpus">000459</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000459</idno>
<idno type="wicri:Area/PubMed/Curation">000459</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000459</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000440</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000440</idno>
<idno type="wicri:Area/Ncbi/Merge">000060</idno>
<idno type="wicri:Area/Ncbi/Curation">000060</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000060</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel.</title>
<author>
<name sortKey="Locher, Christopher P" sort="Locher, Christopher P" uniqKey="Locher C" first="Christopher P" last="Locher">Christopher P. Locher</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Tropical Medicine and Medical Microbiology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii 96816, USA. Christopher.locher@maxygen.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Tropical Medicine and Medical Microbiology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii 96816</wicri:regionArea>
<wicri:noRegion>Hawaii 96816</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ruben, Peter C" sort="Ruben, Peter C" uniqKey="Ruben P" first="Peter C" last="Ruben">Peter C. Ruben</name>
</author>
<author>
<name sortKey="Gut, Jiri" sort="Gut, Jiri" uniqKey="Gut J" first="Jiri" last="Gut">Jiri Gut</name>
</author>
<author>
<name sortKey="Rosenthal, Philip J" sort="Rosenthal, Philip J" uniqKey="Rosenthal P" first="Philip J" last="Rosenthal">Philip J. Rosenthal</name>
</author>
</analytic>
<series>
<title level="j">Antimicrobial agents and chemotherapy</title>
<idno type="ISSN">0066-4804</idno>
<imprint>
<date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>8-Hydroxy-2-(di-n-propylamino)tetralin (pharmacology)</term>
<term>Animals</term>
<term>Buspirone (pharmacology)</term>
<term>Cell Line</term>
<term>Cell Membrane (drug effects)</term>
<term>Cell Survival (drug effects)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Fibroblasts</term>
<term>Humans</term>
<term>Ion Channels (drug effects)</term>
<term>Ligands</term>
<term>Membrane Potentials (drug effects)</term>
<term>Patch-Clamp Techniques</term>
<term>Plasmodium falciparum (drug effects)</term>
<term>Plasmodium falciparum (growth & development)</term>
<term>Receptor, Serotonin, 5-HT1A (drug effects)</term>
<term>Serotonin Antagonists (pharmacology)</term>
<term>Serotonin Receptor Agonists (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>7-Dipropylamino-5,6,7,8-tétrahydro-1-naphtol (pharmacologie)</term>
<term>Agonistes des récepteurs de la sérotonine (pharmacologie)</term>
<term>Animaux</term>
<term>Antisérotonines (pharmacologie)</term>
<term>Buspirone (pharmacologie)</term>
<term>Canaux ioniques ()</term>
<term>Fibroblastes</term>
<term>Humains</term>
<term>Ligands</term>
<term>Lignée cellulaire</term>
<term>Membrane cellulaire ()</term>
<term>Plasmodium falciparum ()</term>
<term>Plasmodium falciparum (croissance et développement)</term>
<term>Potentiels de membrane ()</term>
<term>Relation dose-effet des médicaments</term>
<term>Récepteur de la sérotonine de type 5-HT1A ()</term>
<term>Survie cellulaire ()</term>
<term>Techniques de patch-clamp</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en">
<term>Ion Channels</term>
<term>Receptor, Serotonin, 5-HT1A</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>8-Hydroxy-2-(di-n-propylamino)tetralin</term>
<term>Buspirone</term>
<term>Serotonin Antagonists</term>
<term>Serotonin Receptor Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr">
<term>Plasmodium falciparum</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Cell Membrane</term>
<term>Cell Survival</term>
<term>Membrane Potentials</term>
<term>Plasmodium falciparum</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en">
<term>Plasmodium falciparum</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>7-Dipropylamino-5,6,7,8-tétrahydro-1-naphtol</term>
<term>Agonistes des récepteurs de la sérotonine</term>
<term>Antisérotonines</term>
<term>Buspirone</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Dose-Response Relationship, Drug</term>
<term>Fibroblasts</term>
<term>Humans</term>
<term>Ligands</term>
<term>Patch-Clamp Techniques</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Canaux ioniques</term>
<term>Fibroblastes</term>
<term>Humains</term>
<term>Ligands</term>
<term>Lignée cellulaire</term>
<term>Membrane cellulaire</term>
<term>Plasmodium falciparum</term>
<term>Potentiels de membrane</term>
<term>Relation dose-effet des médicaments</term>
<term>Récepteur de la sérotonine de type 5-HT1A</term>
<term>Survie cellulaire</term>
<term>Techniques de patch-clamp</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To identify new leads for the treatment of Plasmodium falciparum malaria, we screened a panel of serotonin (5-hydroxytryptamine [5HT]) receptor agonists and antagonists and determined their effects on parasite growth. The 5HT1A receptor agonists 8-hydroxy-N-(di-n-propyl)-aminotetralin (8-OH-DPAT), 2,5-dimethoxy-4-iodoamphetamine, and 2,5-dimethoxy-4-bromophenylethylamine inhibited the growth of P. falciparum in vitro (50% inhibitory concentrations, 0.4, 0.7, and 1.5 microM, respectively). In further characterizing the antiparasitic effects of 8-OH-DPAT, we found that this serotonin receptor agonist did not affect the growth of Leishmania infantum, Trypanosoma cruzi, Trypanosoma brucei brucei, or Trichostrongylus colubriformis in vitro and did not demonstrate cytotoxicity against the human lung fibroblast cell line MRC-5. 8-OH-DPAT had similar levels of growth inhibition against several different P. falciparum isolates having distinct chemotherapeutic resistance phenotypes, and its antimalarial effect was additive when it was used in combination with chloroquine against a chloroquine-resistant isolate. In a patch clamp assay, 8-OH-DPAT blocked a P. falciparum surface membrane channel, suggesting that serotonin receptor agonists are a novel class of antimalarials that target a nutrient transport pathway. Since there may be neurological involvement with the use of 8-OH-DPAT and other serotonin receptor agonists in the treatment of falciparum malaria, new lead compounds derived from 8-OH-DPAT will need to be modified to prevent potential neurological side effects. Nevertheless, these results suggest that 8-OH-DPAT is a new lead compound with which to derive novel antimalarial agents and is a useful tool with which to characterize P. falciparum membrane channels.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Gut, Jiri" sort="Gut, Jiri" uniqKey="Gut J" first="Jiri" last="Gut">Jiri Gut</name>
<name sortKey="Rosenthal, Philip J" sort="Rosenthal, Philip J" uniqKey="Rosenthal P" first="Philip J" last="Rosenthal">Philip J. Rosenthal</name>
<name sortKey="Ruben, Peter C" sort="Ruben, Peter C" uniqKey="Ruben P" first="Peter C" last="Ruben">Peter C. Ruben</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Locher, Christopher P" sort="Locher, Christopher P" uniqKey="Locher C" first="Christopher P" last="Locher">Christopher P. Locher</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000060 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000060 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:14638487
   |texte=   5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:14638487" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021